FDA NDC Directory · JSON-LD · Markdown

Aprepitant

NDC 68462-584 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerGlenmark Pharmaceuticals Inc., USA
Marketing categoryAbbreviated NDA (generic) · App ANDA207777
Dosage form / routeCAPSULE · ORAL
Active ingredientsAPREPITANT (80 mg/1)
Marketing started20171012
Package count2

External sources

Source: openFDA. Public-domain (CC0).